Clinical and laboratory studies with tobramycin

Chemotherapy. 1974;20(4):245-56. doi: 10.1159/000221814.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Aminoglycosides / blood
  • Aminoglycosides / pharmacology*
  • Aminoglycosides / therapeutic use
  • Anti-Bacterial Agents / blood
  • Anti-Bacterial Agents / pharmacology*
  • Anti-Bacterial Agents / therapeutic use
  • Bacillus / drug effects
  • Clinical Trials as Topic
  • Drug Synergism
  • Escherichia coli / drug effects
  • Escherichia coli Infections / drug therapy
  • Gentamicins / pharmacology
  • Half-Life
  • Humans
  • Hydrogen-Ion Concentration
  • Klebsiella Infections / drug therapy
  • Male
  • Microbial Sensitivity Tests
  • Proteus / drug effects
  • Pseudomonas Infections / drug therapy
  • Pseudomonas aeruginosa / drug effects
  • Sepsis / drug therapy
  • Serratia marcescens / drug effects
  • Staphylococcus / drug effects
  • Streptococcus / drug effects
  • Time Factors
  • Urinary Tract Infections / drug therapy

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Gentamicins